| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |